Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.

Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community. Michael Dunn explains

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

For any organization, one ill-timed tweet can create enormous backlash.

Voting will close on December 21.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world